CA Stock MarketDetailed Quotes

LABS MediPharm Labs Corp

Watchlist
  • 0.065
  • +0.005+8.33%
15min DelayTrading Sep 13 10:35 ET
26.72MMarket Cap-1625P/E (TTM)

MediPharm Labs Corp Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
78.67%-1.61M
49.98%-1.53M
23.21%-12.34M
977.38%1.47M
-11.95%-3.23M
-1.59%-7.53M
45.54%-3.05M
-21.62%-16.07M
95.85%-168K
-1,088.07%-2.89M
Net income from continuing operations
10.34%-2.58M
-16.94%-3.61M
56.37%-13.08M
47.14%-2.97M
47.68%-4.15M
67.94%-2.88M
58.59%-3.09M
45.29%-29.98M
74.23%-5.61M
-7.82%-7.93M
Operating gains losses
-108.90%-21K
-6,480.00%-319K
-70.47%269K
-100.91%-10K
103.16%38K
-82.28%236K
101.58%5K
131.31%911K
540.56%1.1M
-1,680.26%-1.2M
Depreciation and amortization
5.64%731K
61.22%790K
-12.40%2.52M
32.78%717K
-18.17%617K
-8.83%692K
-40.17%490K
-49.01%2.87M
-77.34%540K
-15.66%754K
Asset impairment expenditure
-83.60%166K
--234K
27.76%1.75M
138.52%433K
-84.58%304K
--1.01M
--0
-89.40%1.37M
-116.87%-1.12M
289.72%1.97M
Remuneration paid in stock
82.76%-80K
101.49%23K
-1,534.33%-1.92M
129.81%48K
-86.44%40K
---464K
---1.55M
-98.03%134K
-102.61%-161K
--295K
Remuneration paid in stock
-2.04%576K
19.81%895K
-29.42%2.03M
-77.99%306K
139.75%386K
1.38%588K
0.81%747K
19.57%2.87M
127.50%1.39M
-62.99%161K
Other non cashItems
103.48%180K
73.06%-66K
-1,420.70%-7.35M
-835.29%-2.23M
357.76%299K
-6,208.54%-5.17M
-421.28%-245K
-104.70%-483K
4.03%-238K
-134.94%-116K
Change In working capital
62.66%-575K
-9.90%528K
-44.70%3.45M
31.34%5.17M
-124.13%-767K
-0.33%-1.54M
-11.08%586K
-1.83%6.24M
65.49%3.94M
-27.41%3.18M
-Change in receivables
-64.56%319K
-2,700.00%-616K
77.74%6.42M
318.87%5.77M
-314.95%-230K
1,204.35%900K
-101.07%-22K
-64.55%3.61M
-79.71%1.38M
-97.14%107K
-Change in inventory
107.68%37K
-106.68%-80K
3,123.30%3.11M
88.96%2.23M
-90.58%172K
78.05%-482K
231.50%1.2M
-104.14%-103K
18.75%1.18M
247.50%1.83M
-Change in payables and accrued expense
68.43%-601K
336.68%1.88M
-446.48%-5.17M
-269.80%-1.27M
-439.27%-1.2M
-535.70%-1.9M
-1,668.89%-796K
118.39%1.49M
119.99%745K
111.83%354K
-Change in other current assets
-37.65%-819K
59.00%159K
-160.89%-1.07M
-291.93%-1.38M
-30.61%807K
-54.15%-595K
-61.24%100K
152.01%1.75M
3.30%719K
--1.16M
-Change in other current liabilities
----
----
129.13%150K
-119.28%-182K
-15.81%-315K
----
----
-147.12%-515K
-126.95%-83K
-282.55%-272K
-Change in other working capital
----
-872.64%-819K
----
----
----
----
--106K
----
----
----
Cash from discontinued investing activities
Operating cash flow
78.67%-1.61M
49.98%-1.53M
23.21%-12.34M
977.38%1.47M
-11.95%-3.23M
-1.59%-7.53M
45.54%-3.05M
-21.62%-16.07M
95.85%-168K
-1,088.07%-2.89M
Investing cash flow
Cash flow from continuing investing activities
-103.70%-35K
2,200.00%525K
33.23%6.87M
-24.49%4.31M
619.94%1.64M
1,187.36%946K
82.64%-25K
14,637.14%5.16M
1,937.50%5.71M
-834.88%-316K
Capital expenditure reported
16.42%-56K
16.00%-21K
45.42%-471K
61.49%-119K
17.72%-260K
28.72%-67K
82.64%-25K
-10.22%-863K
-50.00%-309K
-174.78%-316K
Net PPE purchase and sale
--21K
--326K
--178K
-24,542.86%-1.73M
--1.9M
--0
--0
--0
66.67%-7K
--0
Net business purchase and sale
----
----
-12.50%5.26M
-29.35%4.25M
--0
----
----
--6.01M
--6.01M
--0
Net other investing changes
--0
--220K
27,085.71%1.9M
----
----
----
----
-98.62%7K
----
----
Cash from discontinued investing activities
Investing cash flow
-103.70%-35K
2,200.00%525K
33.23%6.87M
-24.49%4.31M
619.94%1.64M
1,187.36%946K
82.64%-25K
14,637.14%5.16M
1,937.50%5.71M
-834.88%-316K
Financing cash flow
Cash flow from continuing financing activities
-37.21%685K
92.82%-66K
-146.23%-368K
39.60%-241K
-109.09%-299K
-19.30%1.09M
-6,464.29%-919K
-97.14%796K
-40,000.00%-399K
76.17%-143K
Net issuance payments of debt
-40.40%596K
76.91%-269K
-340.20%-944K
27.32%-391K
-40.07%-388K
-21.26%1M
-1,779.03%-1.17M
113.27%393K
-564.20%-538K
-241.98%-277K
Cash dividends paid
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Interest paid (cash flow from financing activities)
-13.27%-111K
-425.00%-21K
-915.38%-264K
-196.15%-77K
-4,350.00%-85K
-4,800.00%-98K
---4K
-116.67%-26K
---26K
--2K
Net other financing activities
5.82%200K
-10.40%224K
95.80%840K
37.58%227K
31.82%174K
125.00%189K
420.83%250K
408.63%429K
75.53%165K
140.12%132K
Cash from discontinued financing activities
Financing cash flow
-37.21%685K
92.82%-66K
-146.23%-368K
39.60%-241K
-109.09%-299K
-19.30%1.09M
-6,464.29%-919K
-97.14%796K
-40,000.00%-399K
76.17%-143K
Net cash flow
Beginning cash position
-16.00%16.93M
-25.53%17.98M
-29.21%24.15M
-33.43%12.95M
-32.97%14.74M
-28.73%20.15M
-29.21%24.15M
71.30%34.11M
-48.75%19.45M
-43.25%21.99M
Current changes in cash
82.60%-956K
73.29%-1.07M
42.31%-5.84M
7.84%5.54M
43.57%-1.89M
10.64%-5.49M
30.64%-4M
-169.16%-10.12M
236.50%5.14M
-318.25%-3.35M
Effect of exchange rate changes
-75.29%21K
--12K
-319.33%-329K
-14.09%-510K
-88.12%96K
163.43%85K
--0
134.97%150K
-432.14%-447K
11,442.86%808K
End cash Position
8.47%15.99M
-16.00%16.93M
-25.53%17.98M
-25.53%17.98M
-33.43%12.95M
-32.97%14.74M
-28.73%20.15M
-29.21%24.15M
-29.21%24.15M
-48.75%19.45M
Free cash from
78.12%-1.66M
49.71%-1.55M
24.34%-12.81M
384.07%1.36M
-9.02%-3.49M
-1.21%-7.6M
46.47%-3.08M
-20.98%-16.93M
88.78%-477K
-794.69%-3.2M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 78.67%-1.61M49.98%-1.53M23.21%-12.34M977.38%1.47M-11.95%-3.23M-1.59%-7.53M45.54%-3.05M-21.62%-16.07M95.85%-168K-1,088.07%-2.89M
Net income from continuing operations 10.34%-2.58M-16.94%-3.61M56.37%-13.08M47.14%-2.97M47.68%-4.15M67.94%-2.88M58.59%-3.09M45.29%-29.98M74.23%-5.61M-7.82%-7.93M
Operating gains losses -108.90%-21K-6,480.00%-319K-70.47%269K-100.91%-10K103.16%38K-82.28%236K101.58%5K131.31%911K540.56%1.1M-1,680.26%-1.2M
Depreciation and amortization 5.64%731K61.22%790K-12.40%2.52M32.78%717K-18.17%617K-8.83%692K-40.17%490K-49.01%2.87M-77.34%540K-15.66%754K
Asset impairment expenditure -83.60%166K--234K27.76%1.75M138.52%433K-84.58%304K--1.01M--0-89.40%1.37M-116.87%-1.12M289.72%1.97M
Remuneration paid in stock 82.76%-80K101.49%23K-1,534.33%-1.92M129.81%48K-86.44%40K---464K---1.55M-98.03%134K-102.61%-161K--295K
Remuneration paid in stock -2.04%576K19.81%895K-29.42%2.03M-77.99%306K139.75%386K1.38%588K0.81%747K19.57%2.87M127.50%1.39M-62.99%161K
Other non cashItems 103.48%180K73.06%-66K-1,420.70%-7.35M-835.29%-2.23M357.76%299K-6,208.54%-5.17M-421.28%-245K-104.70%-483K4.03%-238K-134.94%-116K
Change In working capital 62.66%-575K-9.90%528K-44.70%3.45M31.34%5.17M-124.13%-767K-0.33%-1.54M-11.08%586K-1.83%6.24M65.49%3.94M-27.41%3.18M
-Change in receivables -64.56%319K-2,700.00%-616K77.74%6.42M318.87%5.77M-314.95%-230K1,204.35%900K-101.07%-22K-64.55%3.61M-79.71%1.38M-97.14%107K
-Change in inventory 107.68%37K-106.68%-80K3,123.30%3.11M88.96%2.23M-90.58%172K78.05%-482K231.50%1.2M-104.14%-103K18.75%1.18M247.50%1.83M
-Change in payables and accrued expense 68.43%-601K336.68%1.88M-446.48%-5.17M-269.80%-1.27M-439.27%-1.2M-535.70%-1.9M-1,668.89%-796K118.39%1.49M119.99%745K111.83%354K
-Change in other current assets -37.65%-819K59.00%159K-160.89%-1.07M-291.93%-1.38M-30.61%807K-54.15%-595K-61.24%100K152.01%1.75M3.30%719K--1.16M
-Change in other current liabilities --------129.13%150K-119.28%-182K-15.81%-315K---------147.12%-515K-126.95%-83K-282.55%-272K
-Change in other working capital -----872.64%-819K------------------106K------------
Cash from discontinued investing activities
Operating cash flow 78.67%-1.61M49.98%-1.53M23.21%-12.34M977.38%1.47M-11.95%-3.23M-1.59%-7.53M45.54%-3.05M-21.62%-16.07M95.85%-168K-1,088.07%-2.89M
Investing cash flow
Cash flow from continuing investing activities -103.70%-35K2,200.00%525K33.23%6.87M-24.49%4.31M619.94%1.64M1,187.36%946K82.64%-25K14,637.14%5.16M1,937.50%5.71M-834.88%-316K
Capital expenditure reported 16.42%-56K16.00%-21K45.42%-471K61.49%-119K17.72%-260K28.72%-67K82.64%-25K-10.22%-863K-50.00%-309K-174.78%-316K
Net PPE purchase and sale --21K--326K--178K-24,542.86%-1.73M--1.9M--0--0--066.67%-7K--0
Net business purchase and sale ---------12.50%5.26M-29.35%4.25M--0----------6.01M--6.01M--0
Net other investing changes --0--220K27,085.71%1.9M-----------------98.62%7K--------
Cash from discontinued investing activities
Investing cash flow -103.70%-35K2,200.00%525K33.23%6.87M-24.49%4.31M619.94%1.64M1,187.36%946K82.64%-25K14,637.14%5.16M1,937.50%5.71M-834.88%-316K
Financing cash flow
Cash flow from continuing financing activities -37.21%685K92.82%-66K-146.23%-368K39.60%-241K-109.09%-299K-19.30%1.09M-6,464.29%-919K-97.14%796K-40,000.00%-399K76.17%-143K
Net issuance payments of debt -40.40%596K76.91%-269K-340.20%-944K27.32%-391K-40.07%-388K-21.26%1M-1,779.03%-1.17M113.27%393K-564.20%-538K-241.98%-277K
Cash dividends paid --0--0--0--0--0--0--0--0--0--0
Interest paid (cash flow from financing activities) -13.27%-111K-425.00%-21K-915.38%-264K-196.15%-77K-4,350.00%-85K-4,800.00%-98K---4K-116.67%-26K---26K--2K
Net other financing activities 5.82%200K-10.40%224K95.80%840K37.58%227K31.82%174K125.00%189K420.83%250K408.63%429K75.53%165K140.12%132K
Cash from discontinued financing activities
Financing cash flow -37.21%685K92.82%-66K-146.23%-368K39.60%-241K-109.09%-299K-19.30%1.09M-6,464.29%-919K-97.14%796K-40,000.00%-399K76.17%-143K
Net cash flow
Beginning cash position -16.00%16.93M-25.53%17.98M-29.21%24.15M-33.43%12.95M-32.97%14.74M-28.73%20.15M-29.21%24.15M71.30%34.11M-48.75%19.45M-43.25%21.99M
Current changes in cash 82.60%-956K73.29%-1.07M42.31%-5.84M7.84%5.54M43.57%-1.89M10.64%-5.49M30.64%-4M-169.16%-10.12M236.50%5.14M-318.25%-3.35M
Effect of exchange rate changes -75.29%21K--12K-319.33%-329K-14.09%-510K-88.12%96K163.43%85K--0134.97%150K-432.14%-447K11,442.86%808K
End cash Position 8.47%15.99M-16.00%16.93M-25.53%17.98M-25.53%17.98M-33.43%12.95M-32.97%14.74M-28.73%20.15M-29.21%24.15M-29.21%24.15M-48.75%19.45M
Free cash from 78.12%-1.66M49.71%-1.55M24.34%-12.81M384.07%1.36M-9.02%-3.49M-1.21%-7.6M46.47%-3.08M-20.98%-16.93M88.78%-477K-794.69%-3.2M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data